FEMSelect

Series-B+
femselect.com Biotech & Healthcare
Total Funding $9M
Latest Round Undisclosed Series-B+
Last Announced Feb 3, 2026
Investors Undisclosed
Decision Makers 5 Verified

About FEMSelect

More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website femselect.com
Domain Registered Date Feb 4, 2019

Social & Network Presence

X / Twitter Profile @FEMSelect (60 followers) Created on Jun 2018
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  3. Capital Raise

    Raised $9,000,000 · Series-B+

    fundraisingfox.com

  4. Milestone

    Website domain registered

    femselect.com

  5. Milestone

    X account created (@FEMSelect)

    60 followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for FEMSelect.

Funding History

3 Rounds
Series-B+ · Feb 3, 2026
Series-B+ · May 14, 2025
Series-B+ · Oct 20, 2022

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts